AzTrials
AzTrials

Sensory NeglectNCT02680171

Feasibility and Effectiveness Study of Implementing Prism Adaptation as a Treatment for Spatial Neglect After Stroke

A study testing Prism Goggles and Non-Shifting Goggles in people with Sensory Neglect and Stroke, run by Nova Scotia Health Authority at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Spatial neglect is a common attention disorder after right hemisphere stroke and is associated with decreased independence and quality of life. Despite its high prevalence in the stroke population, there is currently no standard of care for the treatment of neglect. Read more about this study

Who is it for?
Any age
Conditions the study is for
Sensory Neglect, Stroke
What is being tested?
Prism Goggles and Non-Shifting Goggles
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
10 participants
Where
1 siteCanada
Study dates
6 Feb 2018to 30 Aug 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Experience mild to severe symptoms of neglect (as measured by the Sunnybrook Neglect Assessment Procedure and/or as determined based on clinical judgment of the treating team)
  • Be willing to participate
  • Be able to consent to participate
  • Be medically stable
  • Have normal or corrected to normal vision
  • Be able to point to targets presented on a computer screen.

Who cannot join

  • Other neurological disease (e.g., Multiple Sclerosis, Parkinsons disease)
  • Dementia

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Nova Scotia Health Authority

    Halifax, Nova Scotia, B3H3N5

Other trials in Canada

About this study

Official title: Feasibility and Effectiveness Study of Implementing Prism Adaptation as a Treatment for Spatial Neglect After Right Hemisphere Stroke

Spatial neglect is a common attention disorder after right hemisphere stroke and is associated with decreased independence and quality of life. Despite its high prevalence in the stroke population, there is currently no standard of care for the treatment of neglect. Prism adaptation (PA) is a promising rehabilitation technique, however incorporation into clinical care has been limited likely due to the lack of standardized procedures. The investigators have developed a computerized PA technique designed to better engage patients and assist clinicians. In this study the investigators aim to evaluate the feasibility and effectiveness of the computerized PA procedure in a typical health care setting, with the hypothesis that the PA procedure will improve patient's neglect symptoms.

Read the detailed description

There is an unmet need for effective and feasible interventions for spatial neglect after right hemisphere stroke. Neglect is a frequent problem after stroke and makes it difficult for individuals to pay attention and notice information coming from the left side of their world. Thus, they often miss food on the left side of their plate, fail to wash or groom the left side of their face or body, or run into objects on the left side of the hall when walking or using their wheelchair. Neglect is associated with slower recovery, reduced independence, longer stays in rehabilitation and need for more resources when discharged. The investigators have developed a novel and simple computerized prism adaptation (PA) procedure for treating neglect, but the investigators don't know yet whether it is feasible and effective in a typical health care setting. Thus, the purpose of this project is to conduct a randomized, controlled clinical trial, comparing the PA method to a control intervention for the treatment of neglect. The investigators will measure feasibility of use in a clinical setting and effectiveness in terms of impairment (i.e., does PA improve neglect symptoms?), activities (i.e., does having PA improve independence in daily activities) and health care outcomes (i.e., does giving PA shorten length of stay and decrease the need for resources on discharge?). By treating neglect with PA, the overall aim is to improve the health care outcomes for those with neglect and to reduce need for extended hospital care.

A controlled, randomized design will be used in the present study. Patients will be randomly assigned (with stratification related to neglect severity) to PA (experimental) or sham (control) conditions and complete 10, 30-minute intervention sessions over approximately two weeks. These intervention sessions will involve a novel and simple computerized prism adaptation, Peg-The-Mole (PTM). Outcome measures will be collected before and after each treatment, as well as at baseline, and a three month follow-up over the phone.

Being tested
Prism Goggles, Non-Shifting Goggles
Keywords
Cognitive Rehabilitation, Prism Adaptation, Stroke, Spatial Neglect
Medical subject headings
Perceptual Disorders, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prism GogglesBehavioural

    Patients in the experimental condition will wear prism goggles while completing a computerized aiming task. This prisms will shift the patients' vision 10 degrees rightward, causing a recalibration of visuo-motor information. Prism adaptation will be carried out over several days.

  • Non-Shifting GogglesOther

    Also called Control condition

    Non-shifting goggles are worn instead of prism goggles, while completing the same computerized aiming task as those assigned to the prism adaptation.

Study groups in NCT02680171
Study groupRoleWhat they receive
Prism adaptation treatmentExperimentalPrism Goggles with ten-degree rightward deviating prism lenses will be used to implement prism adaptation treatment, in addition to standard care.
Receives: Behavioral: Prism Goggles
Sham prism adaptation treatmentSham comparatorNon-Shifting Goggles (sham) will be worn by patients in the control condition. These goggles do not shift the patients visual field.
Receives: Other: Non-Shifting Goggles

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Sunnybrook Neglect Assessment Procedure (SNAP)

    Test of neglect severity

    Measured: Taken at baseline and after the intervention has been completed (approximately two weeks post-treatment start)

Secondary outcomes (9)
  1. Change in Johnny Shirt Visual Scanning Task

    Test of neglect severity

    Measured: Taken at baseline, after five intervention sessions are completed (approximately 1 week post-treatment start), and after the intervention (approximately two weeks post-treatment start)

  2. Change in Behavioural Inattention Test - Behaviour subtests (BIT-B)

    Test of neglect severity

    Measured: Taken at baseline and after the intervention (approximately two weeks post-treatment start)

  3. Change in Catherine Bergego Scale (CBS)

    Scale of neglect impact on daily activities

    Measured: Taken at baseline and after the intervention (approximately two weeks post-treatment start)

  4. Change in Halifax Neglect Severity Scale

    Scale of neglect impact on daily activities

    Measured: Taken after the intervention (approximately two weeks post-treatment start) and at follow-up (approximately 3 months post-discharge from the Nova Scotia Rehabilitation and Arthritis Centre)

  5. Change in Functional Independence Measure (FIM)

    Measure of functional independence

    Measured: Taken at baseline and at discharge up to 3 months

  6. Frenchay Activities Index

    Measure of functional independence

    Measured: Taken at approximately 3 months post-discharge

  7. Length of inpatient stay at the Rehabilitation Centre

    Measure of hospital utilization

    Measured: From admission to discharge up to 3 months

  8. Discharge destination from Rehabilitation Centre

    Measure of hospital utilization

    Measured: At time of discharge up to 3 months from admission

  9. Change in Proprioceptive and Visuo-motor pointing midline tasks

    Used to assess prism adaptation after-effects

    Measured: Taken from immediately before and at end of treatment session, about 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2016 (estimated)
  2. Study start6 Feb 2018
  3. Primary completion30 Aug 2021
  4. Study completion30 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02680171
Sponsor's protocol ID
TRICSpatialNeglect2016
Status last verified
Jun 2023
First submitted
27 Jan 2016
Last updated
22 Jun 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Champod AS, Taylor K, Eskes GA. Development of a new computerized prism adaptation procedure for visuo-spatial neglect. J Neurosci Methods. 2014 Sep 30;235:65-75. doi: 10.1016/j.jneumeth.2014.05.023. Epub 2014 Jun 19.

    PubMed 24952321
  • Longley V, Hazelton C, Heal C, Pollock A, Woodward-Nutt K, Mitchell C, Pobric G, Vail A, Bowen A. Non-pharmacological interventions for spatial neglect or inattention following stroke and other non-progressive brain injury. Cochrane Database Syst Rev. 2021 Jul 1;7(7):CD003586. doi: 10.1002/14651858.CD003586.pub4.

    PubMed 34196963

Questions about this trial

What is this clinical trial studying?

A study testing Prism Goggles and Non-Shifting Goggles in people with Sensory Neglect and Stroke, run by Nova Scotia Health Authority at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Sunnybrook Neglect Assessment Procedure (SNAP) (time frame: Taken at baseline and after the intervention has been completed (approximately two weeks post-treatment start)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02680171, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in